BioSpace News Archive

Business

Money on the Move: Pheast, Apertura, Aclarion, Reify Health and Mendel Group

Pheast, Apertura and Reify Health are BioSpace’s top financial winners this week. Read on to see what money can do!

April 27, 2022
·
3 min read
·
Hannah Chudleigh
Employer Resources

9 Organization Strategies for Busy Life Science Professionals

It can be difficult to prioritize getting organized, but taking precautionary steps can actually save you time in the long run. To help, here are nine organization strategies for busy professionals.

April 27, 2022
·
5 min read
·
Franklin Carpenter
Business

GSK’s Strong Q1 Driven by COVID-19, Returning Demand for Shingles Vaccine

GlaxoSmithKline exceeded expectations for its first-quarter sales and earnings forecasts. This was largely driven by its sales of Xevudy, an antibody treatment against COVID-19 it developed with Vir Biotechnology, and its Shingrix vaccine against shingles.

April 27, 2022
·
4 min read
·
Mark Terry
Drug Development

Study Suggests Late Stage Asset Lecanemab Could Delay Progression of Alzheimer’s Dementia

New research suggests that treatment with anti-amyloid-beta protofibril antibody lecanemab is estimated to slow the rate of disease progression in patients with Alzheimer’s Disease.

April 27, 2022
·
2 min read
·
Hayley Shasteen
Policy

Ousted Whitehead Institute Researcher David Sabatini Up for Position at NYU

David Sabatini, who was ousted last year by the Whitehead Institute over allegations of sexual harassment, may have found a new home at the NYU Grossman School of Medicine.

April 27, 2022
·
3 min read
·
Alex Keown
Business

Cytovia Goes Public in SPAC Deal Amidst Slow Biotech IPO Environment

Cytovia Holdings, a biopharma company focused on natural killer (NK) cells, merged with special purpose acquisition company (SPAC) Isleworth Healthcare Acquisition Corp. to go public.

April 27, 2022
·
3 min read
·
Mark Terry
Microbiologics Acquires Cryologics

Microbiologics, Inc. the foremost provider of biomaterials and contract microbiology research services, is pleased to announce the acquisition of Cryologics

April 27, 2022
·
2 min read
Policy

Following Gilead’s Lead, J&J Takes Action Against Counterfeit HIV Drugs

Weeks after Gilead Sciences raised concern over counterfeit HIV drugs, Johnson & Johnson has taken similar action against the distribution of counterfeit prescription drugs.

April 27, 2022
·
2 min read
·
Mark Terry
Drug Development

BeiGene, Novartis Drug Tislelizumab Demonstrates Strong Survival Benefit in Esophageal Cancer

BeiGene’s candidate drug tislelizumab for cancer succeeded in meeting the primary endpoint of overall survival in a global Phase III trial. Learn more about it here.

April 27, 2022
·
2 min read
·
Vanessa Doctor, RN
Business

Global Roundup: Exogene Secures Funding to Support TCR Discovery

Exogene nets $2 million to propel the development of its AI platform for T-cell receptor discovery and Healome spins out to deploy a ‘pro-healing’ platform with a focus on ocular surface diseases.

April 27, 2022
·
7 min read
·
Alex Keown